Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.00
Bid: 3.50
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 1.00 (28.571%)
Open: 4.00
High: 4.00
Low: 4.00
Prev. Close: 4.00

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FY2020 Trading Update

25 Jan 2021 07:00

RNS Number : 6780M
Norman Broadbent PLC
25 January 2021
 

Norman Broadbent plc

("Norman Broadbent", "NBB" or the "Group")

FY2020 Trading Update

Norman Broadbent (AIM: NBB) - a leading London quoted Professional Services firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services - provides the following unaudited trading update relating to the twelve months ended 31 December 2020.

Following the unprecedented events of 2020, the Board is pleased to provide the following trading update:

Highlights and Financial Information:

· Management moved early and decisively at start of pandemic

· Group Net Fee Income decreased YoY by 18% to £6.2m (2019: £7.6m)

· Gross margin percentage increased to 79% (2019: 66%)

· Swift cost control measures at onset of pandemic largely offset decrease in Net Fee Income leading to positive Group EBITDA for the full year 2020

· Improved Group liquidity following significant improvement in Debtor Days

· Secured a £250,000 six-year term Coronavirus Business Interruption Loan

· A new £1.5m Invoice Finance Facility to become active in early 2021

· Pre-audit work commenced - Group anticipates releasing the full results for FY2020 in April 2021

· Strategic hires made across 'thrive' sectors and internal promotions to new leadership roles

· Established digital marketing and client engagement initiatives came into their own in 2020.

Mike Brennan, Group CEO of Norman Broadbent, commented:

"2020 was unprecedented yet, despite these unparalleled times, the Norman Broadbent team pulled through and performed. The strategy of building a broader portfolio of services - one we have pursued since I joined the business - stood us in good stead in the run up to, and during, the pandemic. Our broader, more relevant, portfolio of services has enabled us to help clients as they faced their own challenges in 2020. Although our objectives remain the same, the pandemic has amplified them. Put simply, our aim is to help clients manage and successfully drive change, mitigate risk, grow, and succeed.

Notwithstanding the uncertain economic environment, our goal this year is to strive to grow NFI back towards 2019 levels whilst continuing to build upon our successes in 2020 in carefully managing our cost base.

After a tough 2020, I would again like to thank my colleagues for their hard work, innovation and commitment, our clients for placing their continued trust in us, and our supportive shareholders."

Steve Smith, Group CFO/COO of Norman Broadbent, said

"Under the circumstances these are good results reflecting well on our team and strategy. As the pandemic forced businesses to rethink strategy, pivot and change, our clients have increasingly seen us as a problem-solving partner offering a bespoke mix of progressive high‐quality Search, Interim Management, Research & Insight, Assessment & Development solutions. Our collaborative innovative culture coupled with the trusted Norman Broadbent brand has made us proven business partner, especially during these difficult times.

Looking ahead, we continue to seek growth opportunities and are actively pursuing M&A opportunities, long-term partnerships, and strategic 'tuck-ins'." 

For further information please contact:

Norman Broadbent plc

Mike Brennan / Steve Smith - 020 7484 0000

WH Ireland Limited

Adrian Hadden / Jessica Cave / Darshan Patel - 020 7220 1666

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUSOWRAUUAURR
Date   Source Headline
16th Oct 20247:00 amRNSQ3 2024 Trading Update
11th Oct 20244:00 pmRNSDirector/PDMR shareholding
8th Oct 20247:00 amRNSDirector/PDMR Shareholding
3rd Oct 20247:00 amRNSChange of Registered Office
9th Sep 20247:00 amRNSInterim Results
19th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
22nd Jul 20243:46 pmRNSNotification of major holdings
11th Jul 20247:00 amRNSH1 2024 Trading Update
23rd May 20245:29 pmRNSResult of Annual General Meeting
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.